伊伐布雷定在儿童心血管疾病中的应用研究进展
[Research progress in the application of ivabradine in children with cardiovascular diseases].
作者信息
Jiang Lu
机构信息
Department of Cardiology, Children's Hospital of Chongqing Medical University/National Key Clinical Specialty/Ministry of Education Key Laboratory of Child Development and Disorders/National Clinical Research Center for Child Health and Disorders/China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing 400014, China.
出版信息
Zhongguo Dang Dai Er Ke Za Zhi. 2024 Jul 15;26(7):782-788. doi: 10.7499/j.issn.1008-8830.2401072.
Ivabradine, as a specific I current inhibitor, has been widely used in the treatment of chronic heart failure in adults due to its ability to reduce heart rate without affecting myocardial contractility and blood pressure. It has also shown good effects in various types of tachyarrhythmias. However, the application of ivabradine in pediatric cardiovascular diseases still faces many limitations. This article reviews the current research progress on the use of ivabradine in treating pediatric cardiovascular diseases both domestically and internationally, aiming to provide guidance for pediatric cardiologists. .
伊伐布雷定作为一种特异性的I电流抑制剂，因其能够在不影响心肌收缩力和血压的情况下降低心率，已被广泛用于治疗成人慢性心力衰竭。它在各种类型的快速性心律失常中也显示出良好的效果。然而，伊伐布雷定在儿科心血管疾病中的应用仍面临许多限制。本文综述了国内外关于伊伐布雷定治疗儿科心血管疾病的研究进展，旨在为儿科心脏病专家提供指导。
Zotero 插件